- Home
- FEMY vs STEC Comparison
FEMY vs STEC Comparison
Compare FEMY & STEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FEMY
- STEC
- Stock Information
- Founded
- FEMY 2004
- STEC 2006
- Country
- FEMY United States
- STEC Hong Kong
- Employees
- FEMY N/A
- STEC N/A
- Industry
- FEMY Medical/Dental Instruments
- STEC
- Sector
- FEMY Health Care
- STEC
- Exchange
- FEMY Nasdaq
- STEC NYSE
- Market Cap
- FEMY 29.9M
- STEC 63.8M
- IPO Year
- FEMY 2021
- STEC 2021
- Fundamental
- Price
- FEMY $0.83
- STEC $0.74
- Analyst Decision
- FEMY Strong Buy
- STEC
- Analyst Count
- FEMY 3
- STEC 0
- Target Price
- FEMY $8.67
- STEC N/A
- AVG Volume (30 Days)
- FEMY 151.8K
- STEC 10.9K
- Earning Date
- FEMY 08-07-2025
- STEC 08-05-2025
- Dividend Yield
- FEMY N/A
- STEC N/A
- EPS Growth
- FEMY N/A
- STEC N/A
- EPS
- FEMY N/A
- STEC N/A
- Revenue
- FEMY $1,699,232.00
- STEC $10,672,000.00
- Revenue This Year
- FEMY $283.83
- STEC $9,392.20
- Revenue Next Year
- FEMY $161.03
- STEC N/A
- P/E Ratio
- FEMY N/A
- STEC N/A
- Revenue Growth
- FEMY 61.97
- STEC N/A
- 52 Week Low
- FEMY $0.69
- STEC $0.20
- 52 Week High
- FEMY $1.80
- STEC $3.25
- Technical
- Relative Strength Index (RSI)
- FEMY 36.62
- STEC 40.44
- Support Level
- FEMY $0.91
- STEC $0.70
- Resistance Level
- FEMY $0.93
- STEC $0.80
- Average True Range (ATR)
- FEMY 0.04
- STEC 0.08
- MACD
- FEMY -0.01
- STEC 0.00
- Stochastic Oscillator
- FEMY 0.00
- STEC 38.55
About FEMY Femasys Inc.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
About STEC SANTECH HOLDINGS LIMITED
Santech Holdings Ltd is a technology company focusing on exploring various opportunities in consumer technology, consumer healthcare and enterprise technology. It has two revenue segments Wealth management service and Asset management service. Key revenue is generated from Wealth management service.